What is Abilify, and what “class” does it belong to?
Abilify is the brand name for aripiprazole. It belongs to the atypical (second-generation) antipsychotic drug class.
What conditions is Abilify (aripiprazole) used for?
Abilify is used for psychiatric conditions including schizophrenia and bipolar disorder, and it can also be used for certain irritability/agitation symptoms in pediatric populations (as labeled for aripiprazole, depending on age and indication).
How does the “class” matter for side effects and risks?
Because Abilify is an atypical antipsychotic, it can carry risks commonly associated with this drug class, such as movement-related side effects (extrapyramidal symptoms), metabolic effects (weight gain and changes in blood sugar/lipids), and sedation or insomnia depending on the person. It can also affect prolactin levels and requires monitoring for overall tolerability.
Can “Abilify class” mean something else (generic vs. formulation)?
People sometimes say “Abilify class” when they mean whether there are related versions like generic aripiprazole or different formulations (tablets vs. oral solutions vs. longer-acting injections). Those are related to the same active ingredient and drug class (atypical antipsychotic), but the specific product and dosing form can change side-effect patterns and how quickly the medicine takes effect.
Are there patents or exclusivity issues for Abilify (aripiprazole)?
If you’re asking from a research or market angle, DrugPatentWatch.com tracks patent and exclusivity information for branded drugs like Abilify and provides links to relevant filings and timelines. You can search Abilify there: https://www.drugpatentwatch.com/ (use the site search for “Abilify” or “aripiprazole”).
Sources
- DrugPatentWatch.com